Am. J. Respir. Cell Mol. Biol., Vol 13, No. 5, 11 1995, 610-620.
Infection, apoptosis, and killing of mature human eosinophils by human immunodeficiency virus-1
PF Weller, WL Marshall, DR Lucey, TH Rand, AM Dvorak and RW Finberg
Department of Medicine, Harvard Thorndike Laboratories, Charles A. Dana Research Institute, Beth Israel Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA.
Although human eosinophils express low concentrations of CD4, the capacity
of mature, non-replicating eosinophils to be infected with human
immunodeficiency virus-1 (HIV-1) has not been established. Using peripheral
blood eosinophils isolated free of contaminating lymphocytes and
mononuclear leukocytes, we evaluated eosinophil infection with HIV- 1.
Eosinophils could be infected with strains of HIV-1 as evidenced by
HIV-induced cytolytic effects, progressive release of p24 antigen in
cultures of infected eosinophils, recovery of HIV from infected eosinophils
by co-cultivation, and detection of HIV-1 gag viral DNA from infected
eosinophils by polymerase chain reaction (PCR) amplification. Greater p24
antigen release from infected eosinophils was elicited by the phorbol
ester, PMA; and eosinophil killing by HIV-1 was enhanced by the cytokine
GM-CSF. By light and electron microscopy, HIV-infected eosinophils
demonstrated apoptosis and necrosis. Apoptotic subdiploid nuclear staining
was detected by flow cytometric analyses of propidium iodide-stained nuclei
from HIV-infected eosinophils, and DNA isolated from HIV-infected
eosinophils showed both nucleosomal fragmentation and diffuse degradation.
Thus, mature eosinophils, non- replicating terminally differentiated
leukocytes, can be infected with HIV-1. HIV-1 expression in eosinophils is
promoted by increased granulocyte-macrophage colony-stimulating factor
(GM-CSF) and can cause eosinophils to undergo death due to apoptosis and
necrosis.
This article has been cited by other articles:

|
 |

|
 |
 
L. M. Ganley-Leal, P. N. Mwinzi, C. B. Cetre-Sossah, J. Andove, A. W. Hightower, D. M. S. Karanja, D. G. Colley, and W. E. Secor
Correlation between Eosinophils and Protection against Reinfection with Schistosoma mansoni and the Effect of Human Immunodeficiency Virus Type 1 Coinfection in Humans
Infect. Immun.,
April 1, 2006;
74(4):
2169 - 2176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bandeira-Melo, A. Herbst, and P. F. Weller
Eotaxins . Contributing to the Diversity of Eosinophil Recruitment and Activation
Am. J. Respir. Cell Mol. Biol.,
June 1, 2001;
24(6):
653 - 657.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Li, L. Li, R. Wadley, S. W. Reddel, J. C. Qi, C. Archis, A. Collins, E. Clark, M. Cooley, S. Kouts, et al.
Mast cells/basophils in the peripheral blood of allergic individuals who are HIV-1 susceptible due to their surface expression of CD4 and the chemokine receptors CCR3, CCR5, and CXCR4
Blood,
June 1, 2001;
97(11):
3484 - 3490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. ERJEFÄLT, L. GREIFF, M. ANDERSSON, E. MATSSON, H. PETERSEN, M. LINDEN, T. ANSARI, P. K. JEFFERY, and C. G. A. PERSSON
Allergen-induced Eosinophil Cytolysis Is a Primary Mechanism for Granule Protein Release in Human Upper Airways
Am. J. Respir. Crit. Care Med.,
July 1, 1999;
160(1):
304 - 312.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1995 American Thoracic Society.
|
|
|